DNA Methylation of ACADS Promotes Immunogenic Cell Death in Hepatocellular Carcinoma

Overview

Journal Cell Biosci

Publisher Biomed Central

Date 2025 Jan 12

PMID 39800718

Authors

Ze Qian

Yifan Jiang

Yacong Wang

Yu Li

Lin Zhang

Xiaofeng Xu

Diyu Chen

Affiliations

Soon will be listed here.

Abstract

Background: Altered metabolism has become an important characteristic of cancer, and acyl-CoA dehydrogenase short-chain (ACADS), a regulator of lipid synthesis, is involved in carcinogenesis-associated metabolic pathways. DNA methylation is an important mechanism for silencing ACADS in various malignancies. However, the specific role of ACADS in hepatocellular carcinoma (HCC) pathogenesis remains poorly understood.

Methods And Results: Using RNA sequencing data from different tumours in The Cancer Genome Atlas database, we observed that ACADS was downregulated and hypermethylated in HCC. Three potential CpG island sites (cg01535453, cg08618068, and cg10174836) were identified in the ACADS promoter. Through in vivo and in vitro experiments, we confirmed that cg08618068 was methylated in HCC. We defined this site as ACADS methylation site-2 (ACADS MS-2). Methylation of ACADS MS-2 was associated with worse survival, and mutation of MS-2 increased ACADS mRNA levels in five HCC cell lines. Sustained overexpression of ACADS not only suppressed the proliferation, migration, and invasion of HCC cells but also promoted immunogenic cell death (ICD) via the upregulation of calreticulin. Subsequently, we established a specific nomogram based on ACADS methylation levels to evaluate the 3- and 5-year overall survival rates of patients with HCC who underwent surgical resection.

Conclusions: Our work clarified that ACADS acts as a putative tumour suppressor in HCC and confirmed that a nomogram including ACADS methylation had good predictive performance in HCC. We also discovered a correlation between ACADS and ICD, suggesting that ACADS is an essential target for immunotherapy in HCC.

References

McCarthy W, van der Zouwen A, Bush J, Rittinger K . Covalent fragment-based drug discovery for target tractability. Curr Opin Struct Biol. 2024; 86:102809. DOI: 10.1016/j.sbi.2024.102809. View

van Maldegem B, Waterham H, Duran M, van der Vlies M, van Woerden C, Bobu L . The 625G>A SCAD gene variant is common but not associated with increased C4-carnitine in newborn blood spots. J Inherit Metab Dis. 2005; 28(4):557-62. DOI: 10.1007/s10545-005-0557-0. View

Toh M, Wong E, Wong S, Ng A, Loo L, Chow P . Global Epidemiology and Genetics of Hepatocellular Carcinoma. Gastroenterology. 2023; 164(5):766-782. DOI: 10.1053/j.gastro.2023.01.033. View

Kroemer G, Galluzzi L, Kepp O, Zitvogel L . Immunogenic cell death in cancer therapy. Annu Rev Immunol. 2012; 31:51-72. DOI: 10.1146/annurev-immunol-032712-100008. View

Houten S, Wanders R . A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation. J Inherit Metab Dis. 2010; 33(5):469-77. PMC: 2950079. DOI: 10.1007/s10545-010-9061-2. View

Hou J, Zhang H, Sun B, Karin M . The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications. J Hepatol. 2019; 72(1):167-182. DOI: 10.1016/j.jhep.2019.08.014. View

Guri Y, Colombi M, Dazert E, Hindupur S, Roszik J, Moes S . mTORC2 Promotes Tumorigenesis via Lipid Synthesis. Cancer Cell. 2017; 32(6):807-823.e12. DOI: 10.1016/j.ccell.2017.11.011. View

Duan X, Chan C, Lin W . Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy. Angew Chem Int Ed Engl. 2018; 58(3):670-680. PMC: 7837455. DOI: 10.1002/anie.201804882. View

Klutstein M, Nejman D, Greenfield R, Cedar H . DNA Methylation in Cancer and Aging. Cancer Res. 2016; 76(12):3446-50. DOI: 10.1158/0008-5472.CAN-15-3278. View

10.

Schmidt S, Corydon T, Pedersen C, Bross P, Gregersen N . Misfolding of short-chain acyl-CoA dehydrogenase leads to mitochondrial fission and oxidative stress. Mol Genet Metab. 2010; 100(2):155-62. DOI: 10.1016/j.ymgme.2010.03.009. View

11.

Bruix J, da Fonseca L, Reig M . Insights into the success and failure of systemic therapy for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2019; 16(10):617-630. DOI: 10.1038/s41575-019-0179-x. View

12.

Shimada S, Tanaka S . A new era for understanding genetic evolution of multistep carcinogenesis. J Gastroenterol. 2019; 54(7):667-668. DOI: 10.1007/s00535-019-01576-8. View

13.

Pope 3rd E, Kimbrough E, Vemireddy L, Surapaneni P, Copland 3rd J, Mody K . Aberrant lipid metabolism as a therapeutic target in liver cancer. Expert Opin Ther Targets. 2019; 23(6):473-483. PMC: 6594827. DOI: 10.1080/14728222.2019.1615883. View

14.

Liu C, Zhang J, Zheng S, Liu J, Guo J . A novel clinical multidimensional transcriptome signature predicts prognosis in bladder cancer. Oncol Rep. 2018; 40(5):2826-2835. DOI: 10.3892/or.2018.6677. View

15.

Zhang B, Vogelzang A, Fagarasan S . Secreted immune metabolites that mediate immune cell communication and function. Trends Immunol. 2022; 43(12):990-1005. DOI: 10.1016/j.it.2022.10.006. View

16.

Emmett R, Davidson K, Gould N, Arasaradnam R . DNA methylation patterns in ulcerative colitis-associated cancer: a systematic review. Epigenomics. 2017; 9(7):1029-1042. DOI: 10.2217/epi-2017-0025. View

17.

Elnaggar M, Abushouk A, Hassan A, Lamloum H, Benmelouka A, Moatamed S . Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma. Semin Cancer Biol. 2019; 69:91-99. DOI: 10.1016/j.semcancer.2019.08.016. View

18.

Wu D, Yang Y, Hou Y, Zhao Z, Liang N, Yuan P . Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1. Cancer Commun (Lond). 2022; 42(1):37-55. PMC: 8753313. DOI: 10.1002/cac2.12247. View

19.

Yeh C, Wang J, Cheng T, Juan C, Wu C, Lin S . Fatty acid metabolism pathway play an important role in carcinogenesis of human colorectal cancers by Microarray-Bioinformatics analysis. Cancer Lett. 2005; 233(2):297-308. DOI: 10.1016/j.canlet.2005.03.050. View

20.

Borowa-Mazgaj B, de Conti A, Tryndyak V, Steward C, Jimenez L, Melnyk S . Gene Expression and DNA Methylation Alterations in the Glycine N-Methyltransferase Gene in Diet-Induced Nonalcoholic Fatty Liver Disease-Associated Carcinogenesis. Toxicol Sci. 2019; 170(2):273-282. PMC: 6934890. DOI: 10.1093/toxsci/kfz110. View